Kevin Buehler - Net Worth and Insider Trading

Kevin Buehler Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Kevin Buehler owns 1 companies in total, including Precision BioSciences Inc (DTIL) .

Click here to see the complete history of Kevin Buehler’s form 4 insider trades.

Insider Ownership Summary of Kevin Buehler

Ticker	Comapny	Transaction Date	Type of Owner
DTIL	Precision BioSciences Inc	2019-11-08	director

Kevin Buehler Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Kevin Buehler Ownership Network

Ownership Network List of Kevin Buehler

No Data

Ownership Network Relation of Kevin Buehler

Kevin Buehler Owned Company Details

What does Precision BioSciences Inc do?

Who are the key executives at Precision BioSciences Inc?

Kevin Buehler is the director of Precision BioSciences Inc. Other key executives at Precision BioSciences Inc include General Counsel Dario Scimeca , 10 percent owner J. Jefferson Smith , and Chief Medical Officer Alan List .

Precision BioSciences Inc (DTIL) Insider Trades Summary

Over the past 18 months, Kevin Buehler made no insider transaction in Precision BioSciences Inc (DTIL). Other recent insider transactions involving Precision BioSciences Inc (DTIL) include a net sale of 51,036 shares made by Dario Scimeca , a net sale of 310,940 shares made by Michael Amoroso , and a net sale of 29,825 shares made by Alan List .

In summary, during the past 3 months, insiders sold 0 shares of Precision BioSciences Inc (DTIL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 16,536 shares of Precision BioSciences Inc (DTIL) were sold and 3,000 shares were bought by its insiders, resulting in a net sale of 13,536 shares.

Precision BioSciences Inc (DTIL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Precision BioSciences Inc Insider Transactions

No Available Data

Kevin Buehler Mailing Address

Above is the net worth, insider trading, and ownership report for Kevin Buehler. You might contact Kevin Buehler via mailing address: C/o Precision Biosciences, Inc., 302 E. Pettigrew Street, Suite A-100, Durham Nc 27701.

Discussions on Kevin Buehler

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.